NCT06085196

Brief Summary

The goal of this clinical trial is to understand the beneficial role of mindful walking in sustaining cognitive health in African American older adults who have elevated risk of developing neuropsychological diseases. The main question it aims to answer is "Does a multi-session mindful walking intervention lead to promising signals of sustaining cognitive health in vulnerable AA older adults?" The researchers in this 2-arm randomized controlled trial will compare the mindful walking group with a delayed mindful walking to see if the intervention efficacy is observed at multiple follow-up period.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
114

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 16, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 8, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 16, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2024

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

October 16, 2023

Status Verified

October 1, 2023

Enrollment Period

1.1 years

First QC Date

October 8, 2023

Last Update Submit

October 12, 2023

Conditions

Keywords

WalkingMindfulnessLifestyle activity

Outcome Measures

Primary Outcomes (2)

  • Cognitive Function as assessed by the Montreal Cognitive Assessment (MoCA)

    MoCA is a rapid screening instrument for mild cognitive dysfunction. It assesses different cognitive domains: attention and concentration, executive functions, memory, language, conceptual thinking, calculations, and orientation.

    Baseline, 12,18,24 weeks follow-up

  • Everyday Cognition as assessed by the NIH Mobile Toolbox

    The NIH Mobile Toolbox is a smartphone-based, ultra-brief cognitive assessments to measure different domains of cognition using the smartphone screen.

    Baseline, 18, 24 weeks follow-up (4 days each), Weeks 12 and 13 (14 days)

Secondary Outcomes (9)

  • Perceived Quality of Life as assessed by the EuroQol 5 dimensions and 5 levels questionnaire

    Baseline, 12,18,24 weeks follow-up

  • Subjective Physical Activity Levels as assessed by the CHAMPS (Community Health Activities Model Program for Seniors) questionnaire

    Baseline, 12,18,24 weeks follow-up

  • Device-based Physical Activity Levels as assessed by the activPAL Accelerometer

    Weeks 12 and 13 (14 days)

  • Mindfulness Level as assessed by the Mindfulness Attention Awareness Scale and Five Facet Mindfulness Questionnaire

    Baseline, 12,18,24 weeks follow-up

  • Overall Health Status as assessed by the SF-36 self-report survey

    Baseline, 12,18,24 weeks follow-up

  • +4 more secondary outcomes

Other Outcomes (10)

  • Height as measured from the top of the person's head to the heel using digital stadiometer

    Baseline

  • Weight as measured using a digital floor scale

    Baseline

  • Body Mass Index (BMI) as calculated by the height and weight measures

    Baseline

  • +7 more other outcomes

Study Arms (2)

Mindful walking

EXPERIMENTAL

Complete a 24-session outdoor mindful walking intervention over 3 months

Behavioral: Mindful walking activity

Delayed mindful walking group

OTHER

Option to complete a delayed 24-session mindful walking

Behavioral: Mindful walking activity

Interventions

Participate in 24 sessions of outdoor mindful walking on a local walking trail over three months

Delayed mindful walking groupMindful walking

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • African American ages 60 and above
  • Mild symptoms of cognitive decline or MCI
  • Physically inactive or insufficiently active (based on the 2018 US guidelines)
  • Adequate hearing and visual ability to complete study tasks and assessments
  • English proficiency
  • Medically stable with or without medication
  • Capable of providing informed consent
  • Willing to be randomized to one of the two groups

You may not qualify if:

  • Clinical diagnosis of ADRD or other brain abnormalities (e.g., strokes, epilepsy, Parkinson's disease
  • Clinical diagnosis of psychiatric disorders (i.e., depression, post-traumatic stress disorder, bipolar disorder)
  • Unable to walk independently (i.e., need caregiver's assistance) 4) Plan to have surgery or relocate outside the area within the next 6 months
  • \) Currently participate in other studies involving physical activity, mindfulness, or cognitive training

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of South Carolina

Columbia, South Carolina, 29208, United States

RECRUITING

Related Publications (1)

  • Yang CH, Lee J, Wilcox S, Rudisill AC, Friedman DB, Hakun JG, Neils-Strunjas J, Wei J, Miller MC, Byers MD. Implementation and evaluation of a community-based mindful walking randomized controlled trial to sustain cognitive health in older African Americans at risk for dementia. BMC Geriatr. 2024 Jul 4;24(1):579. doi: 10.1186/s12877-024-05090-2.

MeSH Terms

Conditions

Health Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Chih-Hsiang "Jason" Yang, PhD

    University of South Carolina

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chih-Hsiang "Jason" Yang, PhD

CONTACT

Laura Phillips, B.S.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 8, 2023

First Posted

October 16, 2023

Study Start

May 16, 2023

Primary Completion

June 15, 2024

Study Completion

September 30, 2025

Last Updated

October 16, 2023

Record last verified: 2023-10

Locations